Femstat

Femstat

a trademark for an antifungal drug (butoconazole nitrate).
References in periodicals archive ?
Lucas-Schnarre was a Product Director at Wyeth, and she also spent four years with the Consumer Care division of Bayer managing brands including Alka-Seltzer, Midol and Femstat.
com/, examining three of the most notable cases in which branded pharmaceutical shares have been affected by Rx-to-OTC switches: Claritin (loratadine) for Allergy, Pepcid (famotidine) and Tagamet (cimetidine) for Heartburn and Ulcers, as well as Femstat 3 (butoconazole) and Monistat 3 (miconazole) for Vaginal Yeast Infection.
In 1995, P&G introduced Aleve(R), a pain relief medicine, and in 1996, P&G introduced Femstat 3(R), a three-day vaginal yeast infection Rx-to-OTC switch.
For example, they've done great work on Femstat 3 treatments for vaginal yeast infections, Secret antiperspirant and, previously, even Tampax in certain parts of the world," said Denis Beausejour, Procter & Gamble vice president of advertising.
Roche), announced today that it has received FDA clearance to market FEMSTAT One, for the local treatment of vulvovaginal infections caused by Candida albicans.
Under the agreement, KV will receive manufacturing and royalty revenues on the sales of FEMSTAT One in North America and will have semi-exclusive marketing rights in North America and exclusive marketing and licensing rights in the rest of the world.
Roche Laboratories Receives FDA Clearance To Market Femstat One
Roche) has received FDA clearance to market FEMSTAT One, a one day, one dose cure of vulvovaginal infections caused by Candida albicans.
Brands included in the joint venture are Roche's Aleve analgesic and Femstat 3 vaginal yeast infection treatment and Bayer's Actron and Vanquish analgesics, Midol menstrual pain reliever and Mycelex-7 vaginal yeast infection treatment.
Roche will then fully own the Aleve pain reliever and Femstat 3 vaginal yeast infection brands, which P&G has marketed in this JV.
While all other OTC vaginal yeast infection medications require 7 days of treatment, FEMSTAT 3 (butoconazole nitrate 2%) vaginal cream is the first and only 3-day treatment brand available without a prescription.
While all other OTC vaginal yeast infection medications require 7 days of treatment, FEMSTAT 3 (butoconazole nitrate 2%) vaginal cream will be the first and only 3-day treatment brand available without a prescription.